Nuclear Medicine: Page 336

UltraSPECT reaches U.S. milestone

By AuntMinnie.com staff writers

Nuclear medicine firm UltraSPECT of Merrick, NY, has recorded its 100th installation in the U.S.

July 31, 2007

Interest surges in use of imaging for tracking radiation therapy

By Kathlyn Stone

MINNEAPOLIS - How will the imaging community respond to the challenge of quantitative imaging for treatment response? That was the question that multiple speakers set out to answer in a symposium at last week's American Association of Physicists in Medicine (AAPM) meeting. MRI, PET, and SPECT are all being thoroughly scrutinized in order to meet the increasing demand for noninvasive imaging biomarkers that can not only customize treatment, but also track treatment response.

July 30, 2007

Siemens gets IND for study of FLT tracer

By AuntMinnie.com staff writers

Siemens Medical Solutions has received an investigational new drug exemption from the U.S. Food and Drug Administration to conduct a phase I clinical trial of a new radiopharmaceutical for cancer detection.

July 29, 2007

Bristol-Myers Squibb boosts Q2 results

By AuntMinnie.com staff writers

Bristol-Myers Squibb announced revenue increases for the second quarter of 2007 (end-June 30), with sales in its medical imaging unit edging up.

July 26, 2007

ImaRx prices IPO, shares edge lower

By AuntMinnie.com staff writers

Biopharmaceutical company ImaRx Therapeutics picked a rough day to go public. Shares of the Tucson, AZ-based firm fell almost 5% after trading started on the day the Dow Jones Industrial Average lost 310 points.

July 26, 2007

Neoprobe posts Q2 loss on higher sales

By AuntMinnie.com staff writers

Neoprobe of Dublin, OH, announced a net loss for the second quarter, although the firm's revenues edged higher on increased sales of its gamma detection systems.

July 25, 2007